Similar Articles |
|
The Motley Fool February 24, 2010 Brian Orelli |
Medtronic Needs to Regrow a Spine Everything else looks fairly good, but the problem I see involves the slight decline in Medtronic's second-largest segment, spinal products. |
The Motley Fool August 20, 2008 Brian Orelli |
Medtronic Muddles Through The medical device maker manages double-digit growth in a tough market. |
The Motley Fool August 25, 2009 Brian Orelli |
Medtronic Takes the Road Less Traveled It looks like this medical devices company is healthy again. |
The Motley Fool August 24, 2011 Brian Orelli |
Growth, but Not Great Growth Medtronic's growth comes with lower margins. |
The Motley Fool August 24, 2010 Brian Orelli |
Disaster in Medical-Device Land Industry bellwether Medtronic is forecasting a nasty storm. |
The Motley Fool February 20, 2008 Brian Orelli |
Medtronic Looks Ahead After a rough second half of last year, Medtronic is leaving its problems behind, and optimistically focusing on the future. |
The Motley Fool August 22, 2007 Ryan Fuhrmann |
Upbeat About Medtronic The future looks bright at medical-device firm Medtronic, and the stock price is reasonable. First quarter sales grew, as overseas revenue improved an impressive 16%. |
The Motley Fool August 18, 2005 Stephen D. Simpson |
Medtronic Keeps the Beat Strong growth in the ICD and spinal businesses keep Medtronic running. The stock is trading more or less at par to the market with respect to its P/E-to-growth ratio. Investors must decide for themselves whether that's a fair price to pay. |
The Motley Fool February 3, 2011 Brian Orelli |
Add This Stock to Your Show-Me List Wait for the turnaround before investing in Boston Scientific; if it ever comes. |
The Motley Fool May 25, 2011 Brian Orelli |
No Red Carpet for Medtronic's New CEO Omar Ishrak, Medtronic's newly-appointed CEO, looks like he has his work cut out for him trying to get the medical-device maker growing again. |
The Motley Fool February 17, 2009 Brian Orelli |
Investors Heart Medtronic The leaner company is more lovable. |
The Motley Fool August 31, 2011 Harsh Chauhan |
Medtronic Looks Set for Takeoff Medtronic shares jump after flat quarterly growth as it looks toward global expansion. |
The Motley Fool February 17, 2005 Stephen D. Simpson |
Is Medtronic's Heartbeat Slowing? Will gradually decelerating growth lead to a multiple contraction on the medical device maker's stock? |
The Motley Fool November 21, 2007 Rich Smith |
Medtronic Motors Ahead Shares of the medical equipment maker soared yesterday and continue to buck the downtrend on Wall Street, in the wake of a fiscal Q2 2008 earnings report that exceeded expectations for both sales and profits. |
The Motley Fool January 6, 2005 Stephen D. Simpson |
Can Medtronic Still Quicken the Pulse? While increased competition looms for the medical device maker, a shareholder update looks to the past. |
The Motley Fool August 18, 2008 Brian Orelli |
Foolish Forecast: Taking Medtronic to Heart In advance of earnings analysts expect Medtronic, with another medical device approval, to boost revenues 17%. |
The Motley Fool November 24, 2009 Brian Orelli |
52-Week Highs! What's Going On? Even with its recent leap, this stock may belong in your portfolio. Medtronic raised earnings guidance today after a fairly strong quarter, and the stock is hitting new 52-week highs. |
The Motley Fool May 26, 2005 Stephen D. Simpson |
A Second Opinion on Medtronic Medtronic is a growth stalwart, but does valuation properly account for the challenges? |
The Motley Fool May 25, 2010 Brian Orelli |
Medtronic Gets Tossed Out With the Bathwater A bad day to report good news. |
The Motley Fool April 21, 2009 Brian Orelli |
Boston Scientific Rebuilds Whether the company is a value or a value trap depends on how well the rebuilding goes this year. |
The Motley Fool November 21, 2006 Ryan Fuhrmann |
Shocking Results at Medtronic Favorable earnings boost shares of this medical equipment maker -- but are they too high already? |
The Motley Fool April 27, 2010 Brian Orelli |
Boston Scientific's "Challenging" Quarter Boston Scientific fixed its paperwork problem with the Food and Drug Administration earlier this month, but the resulting recall took its toll on first-quarter profits nonetheless. |
The Motley Fool May 24, 2007 Ryan Fuhrmann |
Chronic Healthiness at Medtronic The med-tech firm isn't growing as fast as it once was, but its fourth-quarter earnings report still managed to beat Wall Street's expectations. |
The Motley Fool November 18, 2008 Brian Orelli |
No Buffer for Medtronic Even though sales grew for the quarter, investors weren't happy. |
The Motley Fool November 18, 2004 W.D. Crotty |
Medtronic Down, Not Out Internal defibrillator maker's earnings growth rate is slowing down, but its future looks healthy. |
The Motley Fool April 19, 2007 Billy Fisher |
A Saintly Quarter Shares of St. Jude Medical rise after the company announces a big quarter. |
The Motley Fool May 21, 2008 Brian Orelli |
Medtronic's Endeavors Look Good The medical device maker's new drug-eluting stent helps push up revenue. |
The Motley Fool October 20, 2006 Ryan Fuhrmann |
Boston's Unscientific Results Boston Scientific reported third-quarter results that were at the upper end of the company's late-September earnings warning. The shares have had a rough run lately, down nearly 40% over the past year. Buying opportunity? |
The Motley Fool February 22, 2006 Stephen D. Simpson |
Medtronic's Minor Miss Sluggish sales in several market categories might spook investors. |
The Motley Fool July 29, 2011 Brian Orelli |
Boston Scientific Shows Me The company has shown it can hit its mark for at least one quarter, but can it last? |
The Motley Fool October 16, 2007 Billy Fisher |
A Heartbreaker at Medtronic The medical device maker halts distribution of certain defibrillator wires. Shares of Medtronic are now very close to the stock's 52-week low. |
The Motley Fool March 29, 2011 Brian Orelli |
Medtronic's Exciting New Toys The device maker received multiple approvals in less than a week. |
The Motley Fool May 24, 2006 Stephen D. Simpson |
Measuring Up Medtronic Everyone loves the med-tech firm. That makes it a dangerous investment. |
The Motley Fool May 19, 2009 Brian Orelli |
Medtronic Gets Whacked, Seeks Recovery Device Medtronic gets hammered on lackluster guidance. |
The Motley Fool November 15, 2007 Rich Smith |
Foolish Forecast: Mulling Medtronic In advance of earnings reports, analysts expect sales from the medical-equipment maker to remain flat and profit to fall slightly. |
The Motley Fool February 5, 2008 Brian Orelli |
Boston Scientific Gets Charged Walloped by charges, Boston Scientific posts a loss for the quarter. |
The Motley Fool February 24, 2009 Brian Orelli |
Medtronic Hearts Acquisitions Medical device maker Medtronic pays a little over $1 billion for two acquisitions in one day. |
The Motley Fool July 25, 2006 Ryan Fuhrmann |
A Steady Heartbeat at Edwards Can Edwards Lifesciences grow enough to justify its stock price? |
The Motley Fool February 12, 2004 Jeff Hwang |
Rockin' Medtronic The world's premier medical device maker keeps on growing. |
The Motley Fool July 21, 2010 Brian Orelli |
Boston Scientific Bounces When you're as beaten-down as Boston Scientific, you seemingly have nowhere to go but up. There's also bankruptcy, but the beleaguered medical device maker seems far from that -- at least for now. |
The Motley Fool July 18, 2008 Brian Orelli |
St. Jude Is a Fighter The medical device maker continues to kick the competition while it's down. |
The Motley Fool October 20, 2009 Robert Steyer |
The Heart Company's Disheartening Forecast Boston Scientific scaled back its full-year forecast, and the market doesn't like it. |
The Motley Fool July 19, 2006 Stephen D. Simpson |
Taking St. Jude's Pulse The ICD market is a long-term opportunity, but not a panacea. St. Jude investors should remember that this is a rough neighborhood -- product liability, FDA bureaucracy, and huge, tough competitors live here, too. |
The Motley Fool June 4, 2010 Jim Mueller |
The Changing Face of Abbott Abbott Labs' shift in revenue sources has been a boon over the last five years. |
The Motley Fool April 22, 2010 Brian Orelli |
Abbott's Stuck in a Double-Digit Rut The company keeps cranking out solid earnings, but investors don't seem to care. |
The Motley Fool February 26, 2008 Brian Orelli |
Quick Take: Boston Scientific Gets Approved -- Thrice The medical device maker is granted three FDA approvals in one day. |
The Motley Fool September 14, 2011 Brian Orelli |
How to Muck Up a Turnaround in 12 and a Half Months Boston Scientific's choice for a new CEO has the potential to really muck up its recovery even further -- if that's even possible. |
The Motley Fool May 20, 2009 Brian Orelli |
Joining to Treat, and Beat, Diabetes Medical-device maker Medtronic and drugmaker Eli Lilly are teaming up to co-promote the companies' diabetes products to doctors and patients. |
The Motley Fool June 30, 2011 Brian Orelli |
Medical-Device Makers' Killer: Health-Care Inflation High prices have painted their targets. |
The Motley Fool July 23, 2008 Brian Orelli |
Leaner Boston Scientific Isn't Looking Healthy Investors are rightfully growing weary of Boston Scientific's ability to cut expenses on flat sales, and they send the stock down. |